Assessing quality of life in patients with autoimmune bullous diseases using the Persian version of Treatment of Autoimmune Bullous Disease Quality of Life questionnaire finds similar effects in women as men
Background:. In autoimmune bullous diseases (AIBDs), autoantibodies loosen molecular adhesions in the skin and/or mucosa and lead to blisters and erosions. Immunosuppressive drugs reduce mortality of the AIBD; therefore, patients will have to live longer with comorbidities. Objective:. This study ai...
Main Authors: | Atefeh Behkar, MD, MPH, Gholamreza Garmaroudi, MD, MPH, PhD, Maryam Nasimi, MD, Msc, Shakiba Yousefi, MD, Hasan Khosravi, MD, Nika Kianfar, MD, Dedee F. Murrell, MD, Maryam Daneshpazhooh, MD |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer
2022-03-01
|
Series: | International Journal of Women's Dermatology |
Online Access: | http://journals.lww.com/10.1097/JW9.0000000000000004 |
Similar Items
-
Investigation of comorbid autoimmune diseases in women with autoimmune bullous diseases: An interplay of autoimmunity and practical implications
by: Meropi Karakioulaki, BSc, MSc, MD, et al.
Published: (2022-10-01) -
Exacerbation of Autoimmune Bullous Diseases After Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination: Is There Any Association?
by: Nika Kianfar, et al.
Published: (2022-07-01) -
Rituximab in childhood and juvenile autoimmune bullous diseases as first-line and second-line treatment: a case series of 13 patients
by: Nika Kianfar, et al.
Published: (2022-02-01) -
Correlation of dermal and blood eosinophilia with bullous pemphigoid disease severity
by: Farshad Farnaghi, MD, et al.
Published: (2020-06-01) -
Vulvar involvement in autoimmune bullous diseases.
by: Marren, P, et al.
Published: (1993)